Сон и COVID-19: нейрофизиологические и биохимические аспекты

Сон и COVID-19: нейрофизиологические и биохимические аспекты

Автор: Болдырева Ю.В.

Журнал: Тюменский медицинский журнал @tmjournal

Статья в выпуске: 1 т.23, 2021 года.

Бесплатный доступ

Представлен обзор нейрофункциональных нарушений, развивающихся на фоне Covid-19. Сделан акцент на описание нарушений сна и биологических часов в период пандемии, которая рассматривается как мощный стрессовый фактор, провоцирующий разносторонние нарушения. Большую группу риска составляют лица пожилого возраста и лица с сопутствующей соматической патологией. Приведены данные о влиянии SARS-CoV-2 на другие органы и системы, в частности, на работу иммунной системы.

Covid-19, sars-cov-2, цитокиновый шторм, сон, когнитивные нарушения, психическое здоровье, нарушение сна, депрессия, бессонница, биологические часы, циркадианные ритмы, десинхроноз, иммунитет, вакцинация

Короткий адрес: https://sciup.org/140303370

IDR: 140303370   |   DOI: 10.36361/2307-4698-2020-23-1-22-30

Список литературы Сон и COVID-19: нейрофизиологические и биохимические аспекты

  • Алгахтани Х., Субахи А., Шира Б. Неврологические осложнения коронавируса ближневосточного респираторного синдрома: отчет о двух случаях и обзор литературы. Представитель по делу Neurol Med 2016; 2016:1-6.
  • Биличенко Т. Н., Чучалин А. Г. Заболеваемость и смертность населения России от острых респираторных вирусных инфекций, пневмонии и вакцинопрофилактика. Терапевтический архив. 2018. Т. 90. № 1. С. 22-26.
  • Коровин А. Е., Новицкий А. А., Макаров Д. А. Острый респираторный дистресс-синдром. Современное состояние проблемы. Клиническая патофизиология. 2018. Т. 24. No 2. С. 32-41.
  • Мелёхин А. И. Когнитивно-поведенческая психотерапия расстройств сна. Практическое руководство. М.: ГЭОТАР-Медиа., 2020. 496 с.
  • Светлицкая О. И., Сирош Ю. А., Блатун В. П., Канус И. И. Риск развития острого респираторного дистресс-синдрома у пациентов с внегоспитальными вирусно-бактериальными пневмониями. Экстренная медицина. 2018. Т. 7. № 4. С. 564-569.
  • Центральная роль нейтрофилов в патогенезе синдрома острого повреждения легких (острый респираторный дистресс-синдром). Успехи современной биологии. 2014. Т. 134. № 4. С. 377-394.
  • Чучалин А. Г., Синопальников А. И., Козлов Р. С. и др. Клинические рекомендации по диагностике, лечению и профилактике тяжелой внебольничной пневмонии у взрослых. Клиническая микробиология и антимикробная химиотерапия. 2015. Т. 17. № 2. С. 84-126.
  • Чэнь Р., Ван К., Юй Дж. bioRxiv 2020:030650.
  • AlGhatrif M, Cingolani O, Lakatta EG. (2020) The dilemma of coronavirus disease 2019, aging, and cardiovascular disease: insights from cardiovascular aging science. JAMA Cardiol 5:747-748.
  • Al-Samkari H, Karp Leaf RS, Dzik WH, Carlson JCT, Fogerty AE, Waheed A, Goodarzi K, Bendapudi PK, Bornikova L, Gupta S, et al.. (2020) COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood 136:489-500.
  • Alsolamy S, Arabi YM. (2015) Infection with Middle East respiratory syndrome coronavirus. Can J Respir Ther 51:102.
  • Andersen K. G., Rambaut A., Lipkin V. I. Proximal origin of SARS-CoV-2. Nat Med 2020; 450-452.
  • Auld S, Caridi-Scheible M, Blum JM, Robichaux CJ, Kraft CS, Jacob JT, Jabaley CS, Carpenter D, Kaplow R, Hernandez AC, et al.. (2020) ICU and ventilator mortality among critically ill adults with COVID-19. medRxiv. doi:10.1101/2020.04.23.20076737.
  • Bein T, Weber-Carstens S, Apfelbacher C. (2018) Longterm outcome after the acute respiratory distress syndrome: different from general critical illness? Curr Opin Crit Care 24:35-40.
  • Besedovsky L., Lange T., Haack M. The sleep-immune crosstalk in health and disease // Physiol. Rev. 2019. Vol. 99, № . 10. Р. 1325-1380.
  • Brahim Belhaouari D, Fontanini A, Baudoin JP, Haddad G, Le Bideau M, Bou Khalil JY, Raoult D, La Scola B. (2020) The strengths of scanning electron microscopy in deciphering SARS-CoV-2 infectious cycle. Front Microbiol 11:2014.
  • Bryce C, Grimes Z, Pujadas E, Ahuja S, Beasley MB, Albrecht R, Hernandez T, Stock A, Zhao Z, Al Rasheed M, et al.. (2020) Pathophysiology of SARS-CoV-2: targeting of endothelial cells renders a complex disease with thrombotic microangiopathy and aberrant immune response. The Mount Sinai COVID-19 autopsy experience. medRxiv. Do i:10.1101/2020.05.18.20099960.
  • Cai Y, Zhang J, Xiao T, Peng H, Sterling SM, Walsh RM, Rawson S, Rits-Volloch S, Chen B. (2020) Distinct conformational states of SARS-CoV-2 spike protein. Science 369:1586-1592.
  • Castro RA, Frishman WH. (2021) Thrombotic complications of COVID-19 infection: a review. Cardiol Rev 29:43-47.
  • Coronaviridae Study Group of the International Committee on Taxonomy of Viruses (2020) The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 5:536-544.
  • Craddock K. G. Lymphopenia caused by corticosteroids, immunosuppression and body protection. Trainee. Med., 88 (4) (1978), стр. 564-566.
  • Das G., Mukherjee N., Ghosh S. Neurological insights of Covid-19 pandemic // ACS Chem. Neurosci. 2020. Vol. 11, no. 2. Р. 1206-1211.
  • de Groot RJ, Baker SC, Baric RS, Brown CS, Drosten C, Enjuanes L, Fouchier RA, Galiano M, Gorbalenya AE, Memish ZA, et al.. (2013) Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J Virol 87:7790-7792.
  • Drosten C, Günther S, Preiser W, van der Werf S, Brodt HR, Becker S, Rabenau H, Panning M, Kolesnikova L, Fouchier RA, et al.. (2003) Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 348:1967-1976.
  • Giamarellos-Bourboulis EJ, Netea MG, Rovina N, Akinosoglou K, Antoniadou A, Antonakos N, Damoraki G, Gkavogianni T, Adami ME, Katsaounou P, et al.. (2020) Complex immune dysregulation in COVID-19 patients with severe respiratory failure. Cell Host Microbe 27:992-1000.e1003.
  • Gile J, Scott B, Eckle T. (2018) The period 2 enhancer nobiletin as novel therapy in murine models of circadian disruption resembling delirium. Crit Care Med 46: e600-e608.
  • Grant RA, Morales-Nebreda L, Markov NS, Swaminathan S, Guzman ER, Abbott DA, Donnelly HK, Donayre A, Goldberg IA, Klug ZM, et al.. (2020) Alveolitis in severe SARS-CoV-2 pneumonia is driven by self-sustaining circuits between infected alveolar macrophages and T cells. bioRxiv. doi:10.1101/2020.08.05.238188.
  • Haagmans BL, Al Dhahiry SH, Reusken CB, Raj VS, Galiano M, Myers R, Godeke GJ, Jonges M, Farag E, Diab A, et al.. (2014) Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation. Lancet Infect Dis 14:140-145.
  • Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N, Péré H, Charbit B, Bondet V, Chenevier-Gobeaux C, et al.. (2020) Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369:718-724.
  • Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, Walshaw C, Kemp S, Corrado J, Singh R, et al.. (2021) Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol 93:1013-1022.
  • Hamming Ya., Timens U., Bultuis M. L. K., Lili A. T., Navis J. J. Tissue distribution of ACE 2 protein, a functional receptor for SARS coronavirus. The first step in understanding the pathogenesis of SARS. Patol., 203 (2) (2004). P. 631-637.
  • Haspel J, Kim M, Zee P, et al. A Timely Call to Arms: COVID-19, the Circadian Clock, and Critical Care. J Biol Rhythms. 2021;36 (1):55-70. doi:10.1177/0748730421992587.
  • Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, Merdji H, Clere-Jehl R, Schenck M, Fagot Gandet F, et al.. (2020. b) High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med 46:1089-1098.
  • Helms J., Kremer S., Murji H. J. Med. 2020; 382:2268-70.
  • Hou YJ, Okuda K, Edwards CE, Martinez DR, Asakura T, Dinnon KH, III, Kato T, Lee RE, Yount BL, Mascenik TM, et al.. (2020) SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract. Cell 182:429-446. e414.
  • Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al.. (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395:497-506.
  • Hui KPY, Cheung MC, Perera R, Ng KC, Bui CHT, Ho JCW, Ng MMT, Kuok DIT, Shih KC, Tsao SW, et al.. (2020) Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures. Lancet Respir Med 8:687 695.
  • Iba T, Connors JM, Levy JH. (2020) The coagulopathy, endotheliopathy, and vasculitis of COVID-19. Inflamm Res 69:1181-1189.
  • Kim D, Lee JY, Yang JS, Kim JW, Kim VN, Chang H. (2020) The architecture of SARS-CoV-2 transcriptome. Cell 181:914-921.e910.
  • Korman M, Tkachev V, Reis C, et al. COVID-19-mandated social restrictions unveil the impact of social time pressure on sleep and body clock. Sci Rep. 2020;10 (1):22225. doi:10.1038/s41598-020-79299-7.
  • Kotfis K, Williams Roberson S, Wilson JE, Dabrowski W, Pun BT, Ely EW. (2020) COVID-19: ICU delirium management during SARS-CoV-2 pandemic. Crit Care 24:176.
  • Lambert NJ, Corps S. (2020) COVID-19 “long hauler” symptoms survey report. Indiana University School of Medicine.
  • Lau K. K., Yu W. C., Chu C. M. Possible central nervous system infection by SARS coronavirus. Emerg Infect Dis 2004; 10: 342-344.
  • Li X. C., Zhang J., Zhuo J. L. The vasoprotective axes of the renin-angiotensin system: physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases. Pharmacol Res. 2017; 125: 21-38.
  • Lukan N. (2020) “Cytokine storm,” not only in COVID-19 patients. Mini-review. Immunol Lett 228:38-44.
  • Masters PS, Perlman S. (2013) Coronaviridae. In: Knipe DM, Howley PM, editors. Fields virology. 6th ed. Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins Health. p. 826-847.
  • Miller AJ, Bingaman SS, Mehay D, Medina D, Arnold AC. (2020) Angiotensin- (1-7) improves integrated cardiometabolic function in aged mice. Int J Mol Sci 21:5131.
  • Mônico-Neto, M., Dos Santos, R. V. T., and Moreira Antunes, H. K. (2020). The world war against the COVID-19 outbreak: don’t forget to sleep!. J. Clin. Sleep Med. 16:1215. doi: 10.5664/jcsm.8502.
  • Moore JB, June CH. (2020) Cytokine release syndrome in severe COVID-19. Science 368:473-474.
  • Morin CM, Carrier J. The acute effects of the COVID-19 pandemic on insomnia and psychological symptoms. Sleep Med. 2021;77:346-347. doi:10.1016/j.sleep.2020.06.005.
  • Mudd PA, Crawford JC, Turner JS, Souquette A, Reynolds D, Bender D, Bosanquet JP, Anand NJ, Striker DA, Martin RS, et al.. (2020) Targeted immunosuppression distinguishes COVID-19 from influenza in moderate and severe disease. medRxiv. doi:10.1101/2020.05.28.20115667.
  • Ou X, Liu Y, Lei X, Li P, Mi D, Ren L, Guo L, Guo R, Chen T, Hu J, et al.. (2020) Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun 11:1620.
  • Partinen M. Sleep research in 2020: COVID-19-related sleep disorders. Lancet Neurol. 2021;20 (1):15-17. doi:10.1016/S1474-4422 (20) 30456-7.
  • Pires GN, Ishikura IA, Xavier SD, et al. Sleep in Older Adults and Its Possible Relations With COVID-19. Front Aging Neurosci. 2021;13:647875. doi:10.3389/fnagi.2021.647875.
  • Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, Barnaby DP, Becker LB, Chelico JD, Cohen SL, et al.. (2020) Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA 323:2052-2059.
  • Rogers J. P., Chesney E., Oliver D. Psychiatric and neuropsychiatric presentations related to severe coronavirus infections: a systematic review and meta-analysis compared to the Covid-19 pandemic. Lancet Psychiatry. 2020;7:611-27.
  • Salluh JI, Wang H, Schneider EB, Nagaraja N, Yenokyan G, Damluji A, Serafim RB, Stevens RD. (2015) Outcome of delirium in critically ill patients: systematic review and meta-analysis. BMJ 350: h2538.
  • Schaller T, Hirschbühl K, Burkhardt K, Braun G, Trepel M, Märkl B, Claus R. (2020) Postmortem examination of patients with COVID-19. JAMA 323:2518-2520.
  • Schelling G, Stoll C, Haller M, Briegel J, Manert W, Hummel T, Lenhart A, Heyduck M, Polasek J, Meier M, et al.. (1998) Health-related quality of life and posttraumatic stress disorder in survivors of the acute respiratory distress syndrome. Crit Care Med 26:651-659.
  • Sengupta S, Ince L, Sartor F, et al. Clocks, Viruses, and Immunity: Lessons for the COVID-19 Pandemic. J Biol Rhythms. 2021;36 (1):23-34. doi:10.1177/0748730420987669.
  • Sharma V. K., Jinadatha C. Environmental chemistry is most relevant to study coronavirus pandemics // Environ Chem Lett. 2020. Vol. 8, No. 2. Р. 1-4.
  • Silva, E. S. M. E., Ono, B. H. V. S., and Souza, J. C. (2020b). Sleep and immunity in times of COVID-1. Rev. Assoc. Med. Bras. 66, 143-147. doi: 10.1590/1806-9282.66.S2.143.
  • Slutsky AS, Ranieri VM. (2013) Ventilator-induced lung injury. N Engl J Med 369:2126-2136.
  • Stukalov A, Girault V, Grass V, Bergant V, Karayel O, Urban C, Haas DA, Huang Y, Oubraham L, Wang A, et al.. (2020) Multi-level proteomics reveals host-perturbation strategies of SARS-CoV-2 and SARS-CoV. bioRxiv. doi:10.1101/2020.06.17.156455.
  • Tang L., Wang K., Zhang D., Ding J., Huang K. Lymphopenia predicts the severity of the disease Cavid-19: a descriptive and predictive study. Signal transduction. Goal.Te., 5 (2020) С. 33-33.
  • Thompson BT, Chambers RC, Liu KD. (2017) Acute respiratory distress syndrome. N Engl J Med 377:562-572.
  • Wan Y., Shang J., Graham R., Baric R. S., Li F. Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS. J Virology.2020.
  • Wang B, Li R, Lu Z, Huang Y. (2020. a) Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging 12:6049-6057.
  • Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, et al.. (2020. b) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA 323:1061-1069.
  • Ward SE, Curley GF, Lavin M, Fogarty H, Karampini E, McEvoy NL, Clarke J, Boylan M, Alalqam R, Worrall AP, et al.. (2020) Von Willebrand factor propeptide in severe coronavirus disease 2019 (COVID-19): evidence of acute and sustained endothelial cell activation. Br J Haematol. Epub ahead of print December. doi:10.1111/bjh.17273.
  • Yam LY, Chen RC, Zhong NS. (2003) SARS: ventilatory and intensive care. Respirology 8: S31-S35.
  • Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, et al.. (2020) Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective observational study. Lancet Respir Med 8:475-481.
  • Zaid Y, Puhm F, Allaeys I, Naya A, Oudghiri M, Khalki L, Limami Y, Zaid N, Sadki K, Ben El, Haj R, et al.. (2020) Platelets can contain SARS-CoV-2 RNA and are hyperactivated in COVID-19. medRxiv. doi:10.1101/2020.06.23.20137596.
  • Zhang X, Yang X, Jiao H, Liu X. (2020) Coagulopathy in patients with COVID-19: a systematic review and metaanalysis. Aging 12:24535-24551.
  • Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, Li Q, Jiang C, Zhou Y, Liu S, et al.. (2020) Risk factors of critical & mortal COVID-19 cases: a systematic literature review and metaanalysis.
  • Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, et al.. (2020. a) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395:1054-1062.
  • Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, et al.. (2020) A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382:727-733.
Еще
Статья научная
SciUp 2024 © 2024 ©